<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02635893</url>
  </required_header>
  <id_info>
    <org_study_id>20150605</org_study_id>
    <nct_id>NCT02635893</nct_id>
  </id_info>
  <brief_title>Lower Limb Function After Spinal Cord Injury</brief_title>
  <official_title>Lower Limb Function After Spinal Cord Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shirley Ryan AbilityLab</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Craig H. Neilsen Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shirley Ryan AbilityLab</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, experimental study that examines the physiology of central nervous&#xD;
      system pathways contributing to the control of bilateral movements in individuals with spinal&#xD;
      cord injuries and promotes the recovery of lower-limb motor function through the use of&#xD;
      stimulation and locomotor training.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study plans to examine plasticity in corticospinal synapses of lower-limb muscles. it&#xD;
      has been demonstrated that plasticity elicited at corticospinal synapses in the spinal cord&#xD;
      result in enhancements in electromyographic (EMG) and force activity in upper-limb muscles.&#xD;
      The first step in this proposal is to determine if synaptic plasticity can be elicited in&#xD;
      corticospinal projections targeting lower-limb muscles in humans with SCI.&#xD;
&#xD;
      We will also study methods to strengthen corticospinal plasticity to promote recovery of leg&#xD;
      clearance during training. We will use two novel strategies to enhance plasticity in&#xD;
      corticospinal synapses of lower-limb muscles after SCI: a). administration of an&#xD;
      N-methyl-D-aspartate (NMDA) receptor agonist (i.e. D-cycloserine), and b). Combine&#xD;
      NMDA-induced corticospinal plasticity with training (2D lower limb training and locomotor&#xD;
      training. Corticospinal synaptic plasticity is thought to depend on activation of NMDA&#xD;
      receptors and D-cycloserine enhances motor skill behaviors in animals and humans will be&#xD;
      enhanced by NMDA-induced corticospinal plasticity. An important strength of this aim is the&#xD;
      combination of training and strategies that aimed at enhancing the synaptic efficacy of&#xD;
      residual corticospinal projections. Training effects on physiological pathways will be&#xD;
      explored and correlated with locomotor function&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 21, 2019</start_date>
  <completion_date type="Actual">April 11, 2021</completion_date>
  <primary_completion_date type="Actual">March 9, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in motor evoked potential size</measure>
    <time_frame>30 minutes before and 30 minutes after intervention</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">257</enrollment>
  <condition>Spinal Cord Injury</condition>
  <arm_group>
    <arm_group_label>D-Cycloserine/Placebo + Stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participant will be given a single dose of 100 mg of D-Cycloserine or placebo before receiving stimulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Training+Med/Placebo+Stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participant will be given a single dose of 100 mg of D-Cycloserine or placebo before receiving stimulation followed by training.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Training+Med+Stimulation/Placebo Stim</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participant will be given a single dose of 100 mg of D-Cycloserine or placebo before receiving stimulation or placebo stimulation followed by training.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>D-Cycloserine</intervention_name>
    <description>100 mg of Seromycin by mouth will be administered</description>
    <arm_group_label>D-Cycloserine/Placebo + Stimulation</arm_group_label>
    <arm_group_label>Training+Med+Stimulation/Placebo Stim</arm_group_label>
    <arm_group_label>Training+Med/Placebo+Stimulation</arm_group_label>
    <other_name>Seromycin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>placebo pill will be administered instead of medication by mouth</description>
    <arm_group_label>D-Cycloserine/Placebo + Stimulation</arm_group_label>
    <arm_group_label>Training+Med/Placebo+Stimulation</arm_group_label>
    <other_name>Placebo Drug</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Training</intervention_name>
    <description>walking around a designated track at different speeds both forward and backward</description>
    <arm_group_label>Training+Med+Stimulation/Placebo Stim</arm_group_label>
    <arm_group_label>Training+Med/Placebo+Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stimulation</intervention_name>
    <description>magnetic stimulation and electrical stimulation may be applied</description>
    <arm_group_label>D-Cycloserine/Placebo + Stimulation</arm_group_label>
    <arm_group_label>Training+Med+Stimulation/Placebo Stim</arm_group_label>
    <arm_group_label>Training+Med/Placebo+Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo Stimulation</intervention_name>
    <description>this is a fake stimulation that is administered but will be unknow to the subject.</description>
    <arm_group_label>Training+Med+Stimulation/Placebo Stim</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  4. Inclusion criteria for individuals with SCI:&#xD;
&#xD;
               -  Male and females between ages 18-85 years of age&#xD;
&#xD;
               -  SCI ( â‰¥1 month of injury)&#xD;
&#xD;
               -  ASIA A, B,C and D&#xD;
&#xD;
               -  SCI above L5&#xD;
&#xD;
               -  Able to perform a visible contraction with dorsiflexor and hip flexor muscles&#xD;
                  (allowing testing of largely impaired patients)&#xD;
&#xD;
               -  Able to ambulate a few steps with or without an assistive device&#xD;
&#xD;
        Inclusion criteria for healthy controls:&#xD;
&#xD;
          -  Male and females between ages 18-85 years of age&#xD;
&#xD;
          -  Able to walk and complete lower-limb tests with both legs&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Exclusion criteria for individuals with SCI&#xD;
&#xD;
          -  Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic&#xD;
             disease,&#xD;
&#xD;
          -  Any debilitating disease prior to the SCI that caused exercise intolerance&#xD;
&#xD;
          -  Premorbid, ongoing major depression or psychosis, altered cognitive status&#xD;
&#xD;
          -  History of head injury or stroke,&#xD;
&#xD;
          -  Metal plate in skull&#xD;
&#xD;
          -  History of seizures&#xD;
&#xD;
          -  Receiving drugs acting primarily on the central nervous system, which lower the&#xD;
             seizure threshold such as antipsychotic drugs (chlorpromazine, clozapine) or tricyclic&#xD;
             antidepressants.&#xD;
&#xD;
          -  Pregnant females, and&#xD;
&#xD;
          -  Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinal&#xD;
             cord disease such as spinal stenosis, spina bifida or herniated cervical disk.&#xD;
&#xD;
        Exclusion criteria for healthy controls:&#xD;
&#xD;
          -  Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic&#xD;
             disease,&#xD;
&#xD;
          -  Any debilitating disease that causes exercise intolerance&#xD;
&#xD;
          -  Premorbid, ongoing major depression or psychosis, altered cognitive status&#xD;
&#xD;
          -  History of head injury or stroke,&#xD;
&#xD;
          -  Metal plate in skull&#xD;
&#xD;
          -  History of seizures&#xD;
&#xD;
          -  Receiving drugs acting primarily on the central nervous system, which lower the&#xD;
             seizure threshold such as antipsychotic drugs (chlorpromazine, clozapine) or tricyclic&#xD;
             antidepressants.&#xD;
&#xD;
          -  Pregnant females, and&#xD;
&#xD;
          -  Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinal&#xD;
             cord disease such as spinal stenosis, spina bifida or herniated cervical disk.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Monica A Perez, PT, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shirley Ryan AbilityLab</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Shirley Ryan Ability Lab</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>December 11, 2015</study_first_submitted>
  <study_first_submitted_qc>December 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2015</study_first_posted>
  <last_update_submitted>June 29, 2021</last_update_submitted>
  <last_update_submitted_qc>June 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shirley Ryan AbilityLab</investigator_affiliation>
    <investigator_full_name>Monica Perez</investigator_full_name>
    <investigator_title>Chair Arms + Hands Lab</investigator_title>
  </responsible_party>
  <keyword>SCI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cycloserine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

